GSC
BIO icon

Ground Swell Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Ground Swell Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$33K Buy
+287
New +$34K 0.06% 333

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ground Swell Capital's BIO Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Bio-Rad Laboratories Class A (BIO) in Q3 2014: 287 shares worth $33K. The stake represents 0.06% of the portfolio and ranks #333 among its holdings.

200 funds tracked by Wall St. Rank hold BIO as of Q3 2014.

  • Ground Swell Capital held 287 shares of Bio-Rad Laboratories Class A worth $33K as of Q3 2014.
  • Bio-Rad Laboratories Class A was a new Ground Swell Capital position in Q3 2014.
  • Bio-Rad Laboratories Class A made up 0.06% of Ground Swell Capital's portfolio in Q3 2014, its #333 holding.
  • 200 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.